WCN Report: Palliative Care Is Gaining Momentum

By Professor Gian Domenico Borasio, Lausanne, Switzerland
and Professor David Oliver, Canterbury, U.K.

Modern palliative care traces its origins to the pioneering work of Dame Cicely Saunders who founded the first modern hospice, St. Christopher’s Hospice, in 1967 in London. Although most patients in St. Christopher’s suffered from cancer (as indeed most patients followed by palliative care teams to this day), a small group of patients did not. From the beginning, a few beds were reserved for patients with amyotrophic lateral sclerosis (ALS).

ALS has since become a paradigm disease for non-oncological palliative care, and it was the first non-cancer disease to have a textbook devoted to its palliative care to be published (albeit as late as in 2000).1 In 2016, a consensus document on palliative care and neurology was produced by the European Academy of Neurology and the European Association for Palliative Care.2

The World Health Organization (WHO) definition of palliative care states that “palliative care is an approach which improves quality of life of patients and their families facing life-threatening illness.”3 There can be little doubt that a large proportion of neurological patients fall into this category.4 Indeed, given the progressive clinical course and the lack of curative options for most neurodegenerative disorders, one would assume that neurological patients and their families would stand to benefit greatly from an integration of the palliative approach into neurological practice.

Palliative Care on the Program

For the first time in the history of the World Congress of Neurology, two sessions on palliative care were held as part of the scientific program in Kyoto. The sessions were organized by Professor Wolfgang Grisold, secretary general of the WFN, and Professor Gian Domenico Borasio, neurologist and chair in palliative medicine at the University of Lausanne in Switzerland.

The first session, which covered the general concepts of palliative care, opened with a remarkable talk by Dr. Rajagopal from Kerala, India. Dr. Rajagopal has created an impressive palliative care network in an extremely resource-poor environment. He poignantly reminded us that palliative care in developing countries must respond to other problems than in industrialized ones, but that it is no less important. Following up on this, Professor Ogino, of Narita, Japan, described the challenges of palliative care from a transcultural perspective. There are large differences between Asian and European countries in the percentage of people dying at home, the opioid administration at the end of life, and the legal regulations for the end of life. However, a common feature across many countries is the fact that palliative care is mostly, if not exclusively, available for cancer patients, while access to palliative care for neurological patients remains challenging. Prof. Borasio approached the sensitive topic of end-of-life decisions in neurology, focusing on the crucial role of medical indication and the need for good communication skills on the neurologists’ side.5

In the second session, which was devoted to clinical examples of neurological palliative care, Professor Monika Führer, of Munich, Germany, showed impressive data on neurological involvement in pediatric palliative care, which turns out to be present and significant in 75 percent of patients.6 Cancer accounts for only about 20 percent of pediatric palliative care patients, further underscoring the importance of neurological palliative care in this context.

Prof. Grisold provided a description of the needs and problems faced by patients with advanced neuro-oncological disorders, which are compounded by the progressive loss in decision-making capacity and the emergence of behavioral disturbances.7 Professor David Oliver, who also is a board member of the European Association for Palliative Care, described in detail the manifold possibilities that palliative care offers to improve the quality of life of patients with ALS and their families. Often enough, these measures also have a demonstrable positive effect on patient survival as well.8

The sessions were well attended, and the discussants highlighted their own experiences from places as diverse as Australia, Europe, Japan, and Sri Lanka. Common themes were the difficulty to provide adequate palliative care to neurological patients, the lack of evidence-based guidelines, and the challenge of colleagues confusing palliative care with terminal care.

We sincerely hope that future WCN meetings will continue to offer attendees the possibility to hear about the most recent developments for this crucial topic for clinical neurological practice.

References

  1. Oliver D, Borasio GD, Johnston W.(eds) Palliative care in amyotrophic lateral sclerosis: form diagnosis to bereavement. 3rd edition. 2014. Oxford. Oxford University Press.
  2. Oliver DJ, Borasio GD, Caraceni A, de Visser M, Grisold W, Lorenzl S, Veronese S, Voltz R. A consensus review on the development of palliative care for patients with chronic and progressive neurological disease. Eur J Neurol 2016;23:30-38.
  3. Sepulveda C, Marlin A, Yoshida T, Ullrich A. Palliative Care: The World Health’s Organization global perspective. J Pain Symptom Manage 2002;24:91-96
  4. Borasio GD. The role of palliative care for patients with neurological diseases. Nat Rev Neurol 2013;9:292-295
  5. Borasio GD, Jox R. Choosing wisely at the end of life: the crucial role of medical indication. Swiss Med Wkly 2016:146:w14369
  6. Bender HU, Riester MB, Borasio GD, Führer M. “Let’s bring her home first.” Patient characteristics and place of death in specialized pediatric palliative home care. J Pain Symptom Manage 2017;54:159-166
  7. Pace A, Dirven L, Koekkoek JAF, et al. European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma. Lancet Oncol 2017;18(6):e330-e340
  8. Mitchell D, Borasio GD. Amyotrophic lateral sclerosis/motor neurone disease. Lancet 2007;369:2031-2041

AFAN Supports Young Neurologists

By Prisca-Rolande Bassolé, Professor Amadou Gallo Diop, and Professor
Mouhamadou Mansour Ndiaye

Young neurologist Prisca-Rolande Bassolé, (center), meets WFN President Raad Shakir (left) and Amadou Gallo Diop, the Africa Initiative Task and Advisory Force for Africa Trustee, at the first AFAN Conference in Tunisia.

The inaugural meeting of the African Academy of Neurology (AFAN) took place in August 2015 in Dakar, Senegal. In a brief presentation, two young African neurologists identified and summarized the expectations of their generation about this African academy1.

Two years later, the first AFAN conference took place March 15-18 in Yasmine- Hammamet, Tunisia. It was co-organized by the Tunisian Society of Neurology and the Pan Arab Union of Neurological Societies, which met at the same time with the help of the International Auspices. Members of the International Auspices are the World Federation of Neurology, the European Academy of Neurology, the American Academy of Neurology, the Movement Disorders Society, the International League Against Epilepsy, and the Middle East North African Committee for Treatment and Research in Multiple Sclerosis2.

The conference represented a great opportunity to enhance regional and international cooperation with these other societies and organizations and to improve the education of young African neurologists.

Residents and young neurologists with the teachers at the International Course of Neurology on the Peripheral Nerve and Muscular Diseases, presented May 8-9 at Cheikh Anta Diop University.

AFAN is committed to participating in the training and continuing medical education of young neurologists. Two months after this first conference, AFAN organized the International Course of Neurology on Peripheral Nerve and Muscular Diseases with the Pan African Association of Neurological Sciences and the French Society of Neurology. The course took place May 8-9 at Cheikh Anta Diop University in Dakar, Senegal. Seventy residents and young neurologists from 18 countries attended the course. The attendees represented Benin, Burkina Faso, Burundi, Cameroon, Congo, Congo Brazzaville, the Democratic Republic of Congo, Djibouti, Gabon, Guinea Conakry, Ivory Coast, Mali, Maroc, Niger, Rwanda, Senegal, Tchad, and Tunisia.

Attendees benefited from the interactive topics that were presented over two days by teachers from France, Ivory Coast, and Senegal.

This is an excellent initiative of AFAN that the younger generation of African neurologists encourages. We hope that other courses like this one will be organized periodically to foster interregional and international cooperation and to improve the training of neurologists. •

References

  1. Bassolé PR, Fogang FY, The African Academy of Neurology: Young African Neurologists’ Message and Point of View; World Neurology, 2016 Jul;31(4):6
  2. Gouider R, Grisold W, AFAN-PAUNS Congress: Two societies achieve a milestone of joint regional meetings; World Neurology, 2017 May-Jun;32(3):12

Prisca-Rolande Bassolé is an African neurologist from Burkina Faso. Amadou Gallo Diop is an Africa Initiative Task and Advisory Force for Africa Trustee. Mouhamadou Mansour Ndiaye is the first president of AFAN and a member of the Neurology Department/FANN Teaching Hospital in Dakar, Senegal. The authors declare no conflicts of interest.

From Islamabad to Kyoto: A Dream Come True

By Dr. Qurat Ul Ain
Islamabad, Pakistan

Dr. Quratul Ain (center), Professor Arsalan Ahmad (second from right), and Professor Hideki Mochizuki (third from right) at one of the WCN 2017 events they attended.

The XXIII World Congress of Neurology 2017 took place Sept. 16-21 in Kyoto, Japan. It was organized by the World Federation of Neurology (WFN) and co-hosted by the Japanese Society of Neurology (JSN) and Asian and Oceanian Association of Neurology (AOAN). More than 8,600 delegates attended this conference from 121 countries.

As a medical student and an intern, I have presented papers and posters in local and national neurology conferences in Pakistan over the last three years. When my teacher and mentor, Professor Arsalan Ahmad, asked me to submit our abstract to the WCN in Kyoto, I asked him who would sponsor it. “Apply for a bursary” was his immediate response. I was overjoyed when my abstract was accepted for a poster presentation and I was awarded a travel bursary of $1,000 with free registration. Preparing the poster and traveling to Japan was a long journey from Pakistan, yet an amazing one to write about.

The International Conference Center Kyoto is a striking architectural beauty with breath-taking scenery and lakes surrounded by green mountains. The main hall offers an amazing interior and a huge seating capacity; the smaller halls are equally as beautiful.

The scientific sessions, teaching courses, plenary lectures, and the hall filled with research posters and enthusiastic presenters each day was very interesting. The Japanese cultural flavor and politeness displayed throughout the conference was impressive. Professor Edvard I. Moser, the Norwegian Nobel laureate, presented a lecture during the Presidential Symposium that was both exciting and inspiring. A session on the Zika virus with graphic visuals by Professor Andre Pessoa of Brazil also was interesting.

Despite an unexpected typhoon threat, the Opening Ceremony on Sept. 17, in the presence of the prince and princess of Japan, was superb. The reception dinner featured a dramatic Taiko drum performance. The thundering Taiko beats in the air were mesmerizing. It filled the exhibition hall with immense energy.

I enjoyed my brief visit to Kyoto, a city that is rich in tradition, with its sprawling street markets and ancient temples. During my morning walk on Manjuyacho Street near my hotel, I heard the temple bell at 6 a.m. Following the resonance, I reached an ancient Buddhist temple. It provided a serene aura, and the glimpse of that moment will be remembered. I later learned that the temple bell is also called “bonsho” in Japan. It is used to summon monks for prayer or to demarcate time.

The icing on the cake was a dinner hosted by Congress President Professor Hidehiro Mizusawa. I attended the dinner with Prof. Ahmad. It was a majestic traditional event that included a martial arts performance by children and adults as well as a traditional dance performance by Maikos. I had the rare opportunity to talk to a Maiko and learn more about them. This was followed by a sumptuous nine-course meal. Professor Hideki Mochizuki from Osaka University went out of his way to elaborate on the cultural performances and taught me to eat sushi with chopsticks.

The hospitality of the Japanese nation, the energy of the conference, and enlightening lectures from renowned neurologists throughout the conference provides an experience and memories that I will cherish for a long, long time.

Regional WHO Meeting Update

By Wolfgang Grisold

The World Federation of Neurology (WFN) was invited to participate in the World Health Organization (WHO) meeting that took place Sept. 11-14 in Budapest.

Regional Director Zsuzsanna Jakab (left) speaks with WFN Professor Wolfgang Grisold, WFN secretary general.

The agenda included a review of the current work of the WHO, presented by the regional director, Zsuzsanna Jakab. Statements came from the Hungarian government (Prime Minister Viktor Orban) and individual European countries. WHO Director General Dr. Tedros Adhanom Ghebreyesus explained his ideas on the future development of the WHO.

The WFN was invited as a permanent member. Several non-governmental organizations (NGOs) and non-state actors participated, including the World Stroke Organization (WSO), represented by Professor Patrik Michel.

WHO Director General Dr. Tedros Adhanom Ghebreyesus outlines his vision of the WHO during its regional meeting for Europe.

The WFN was invited to provide a statement, which it chose from agenda item 5b referring to the environment and neurology. This statement was developed by using the work done by a WFN applied research group on neurology and the environment. This research group met in 2016 in Strasbourg and emphasized the importance of the environment and its effect on neurologic diseases. The final version of the report as accepted is posted at who.int/en/. The written statement has been posted at euro.who.int/en/about-us/governance/regional-committee-for-europe/67th-session/statements-from-non-state-actors.

Crown Princess Mary of Denmark, the patron of WHO European region, speaks at the WHO Regional Committee for Europe.

Also present were the WSO and several other NGOs with overlapping fields in neurology, such as palliative care, occupational therapy, and student representation (IFSMA).

The cooperation of the WFN with the WHO is important and has included several successful projects, such as the Atlas of Neurology, the ICD-11 classification, and future work on non-communicable diseases.

The WFN participating with the WHO in regional meetings is extremely important as it gives neurology a local voice in the important regional aspects of WHO work. 

Practical Neurology in Moshi, Tanzania Initiative Aims to Train 200 Neurologists

By William P. Howlett, Marieke Dekker, and Sarah Urasa (KCMC)

Sarah Urasa

Marieke Dekker

William P. Howlett

In August 2015, the African Academy of Neurology (AfAN) was formed in Dakar, Senegal, and became the final regional member of the World Federation of Neurology (WFN). This membership is proving to be an important stimulus to neurology education and training in Africa.

A subsequent meeting of AfAN and regional members of the WFN, which took place at the World Congress of Neurology in November 2015 in Santiago, Chile, adopted a resolution to promote the training of 200 neurologists in Africa within the following 10 years.

Since then, in order to achieve this goal, a number of initiatives have taken place in Africa. One such initiative involves the East African Development Bank (EADB), an organization that currently includes four countries: Kenya, Rwanda, Tanzania, and Uganda. It involves funding a Medical Training and Fellowship (METAF) program, which is designed to support the neglected fields of neurology and oncology in East Africa.

The neurology program includes support for one- to two-year training fellowships in the U.K. for African neurology trainees and support for local training in neurology within East Africa.

Partnership

Group photo of course trainees, lecturers, and organizers.

The METAF program is planned in collaboration with local organizing partners and involves teaching hospitals and universities in East Africa and the Royal College of Physicians London (RCP) supported by representatives from the Association of British Neurologists (ABN) and managed by the British Council. Postgraduate doctors either training in internal medicine or pediatrics, or those recently graduated, are their target audience. The aim is to increase knowledge and awareness of neurology in Africa and to promote training in neurology, ranging from primary care to specialist neurologists.

To facilitate the implementation of METAF locally, adjacent countries—Tanzania/Kenya and Uganda/Rwanda—were paired into two groups with a series of two five-day courses planned per year, alternating between the host countries within each group. The setup was planned to continue for four years. Members of the teaching faculty for each course are chosen from the two host countries, with visiting lecturers from
the U.K.

The first series of these courses took place in September 2016 in Nairobi, Kenya, and Kampala, Uganda. A total of 34 trainees participated. The third course took place April 3-7 in Moshi in Northern Tanzania. It was attended by 20 trainees.

Practical Neurology Theme

The venue in Moshi was a local hotel with conference facilities. The theme of the Moshi course was “Practical Neurology,” with a comprehensive but practical review of the main neurological disorders experienced in Africa occurring in all ages. It also included a hands-on neurological examination. The course started and finished with a short pre- and post-training assessment. The covered topics ranged from infections— including HIV—to epilepsy, stroke, paraplegia, neuropathy, movement disorders, dementia, head injury, cerebral palsy, and genetic diseases. Interspersed between formal lectures were teaching video sessions and case presentations by the participants.

The course highlighted some important aspects for future neurology training in Africa. First, it is a practical example of a global AfAN/WFN initiative, which is funded from within Africa, supporting sustainability in the longer term. Second, it has resulted in North/South collaboration with neurologists/lecturers from within Africa and the U.K. coming together for the first time, all with the aim of teaching and training neurology in Africa. Third, the importance of participatory teaching methodology was underlined by the shared interest and excitement shown by the trainees, in particular with their case presentations and group discussions.

Ophthalmoscopy Exams

Trainee using an Arclight ophthalmoscope in the workplace.

An example of instant success was the provision of an affordable, handy, lightweight, easily rechargeable Arclight Ophthalmoscope free to everyone in the course, including teachers. This was introduced by David Nicholl, ABN honorary secretary. The candidates in the course were instructed on how to use the Arclight. The effect was palpably electric as they started to learn a practical skill and realized they could carry out funduscopic examinations upon returning to their workplaces across Tanzania.   

The course is just one of a number of ongoing initiatives aimed at developing neurology training in Africa. In the past five years, the Eastern African region has seen some significant developments, with adult and pediatric neurologists from the East African Community (EAC) countries of Burundi, Kenya, Rwanda, Tanzania, and Uganda joining forces professionally. The aim is to facilitate specialist neurology training for EAC doctors within Africa to make the region less dependent on external training facilities. This was supported by grants-in-aid from the WFN.

Tanzania has a population of 53 million and only seven practicing neurologists, and has huge unmet needs in neurology. One author (Dr. Howlett) has worked at Kilimanjaro Christian Medical Center (KCMC) in Northern Tanzania for over 30 years. He has experienced the start of neurology teaching/training of assistant medical officers followed by undergraduates, later postgraduates, and the training of one specialist in neurology. The same changes are happening all over Africa today. The historical post-colonial gap in neurology teaching/training and skills in Africa is well known; this neurology teaching course is another small step toward closing that gap. 

The authors are with the Kilimanjaro Christian Medical Center.

Peripheral Nerve Society Meeting in Sitges, Spain

Mitochondrial transport down dorsal root ganglion axons is impaired by saturated fatty acids, a likely mechanism leading to energy loss and axonal neuropathy in Type 2 diabetes. The slide is from a lecture from Prof. Eva Feldman’s lab.

The 13th Congress of the Peripheral Nerve Society (PNS) took place July 8-13, in Sitges, Spain. The PNS hosts annual congresses, and the next congress will be in July 2018 in Baltimore, Maryland. In 2019, it will take place in Genoa, Italy.

For the International Congress on Neuromuscular Diseases (ICMND) 2018 in Vienna, the Neuromuscular Congress of the Research Group on Neuromuscular Disease of WFN, it is planned that a joint session of the PNS and ICNMD will take place.

The Congress of the PNS is devoted to the peripheral nerves, not only on clinical entities, but building the gap between basic research and toward the clinical implications.

This year, there were 500 participants from more than 50 nations. The PNS has a strong emphasis on education, and about 100 young participants were sponsored to attend the meeting in order to present posters and platform presentations.

The scientific content contained many basic and translational aspects, such as the molecular aspects of node of Ranvier, the metabolic support of axons by Schwann cells, and the new models of auto-immunity to nodal components. Also, pain and ion channels were discussed in plenary lectures.

Sitges, Spain, proved to be an attractive site for the Peripheral Nerve Society Meeting with excellent meeting facilities and attractive beaches.

One of the concerns of the PNS is the research and treatment of inflammatory neuropathies. Treatment studies and open questions were discussed. Another important aspect is diabetic neuropathy, where worldwide an increase of diabetes as a noncommunicable disease is being observed. Mechanisms and possible treatments were discussed. The role of changing food habits, lack of exercise, and lifestyle seem to contribute to this development. A future strategy in a worldwide campaign against diabetic neuropathy was initiated.

Several papers and posters addressed issues of genetic neuropathies. Increasingly, chemotherapy-induced neuropathies are attracting attention, not only in regard to prevention, but also pain treatment and management.

Neuropathic pain was a topic, and ion channels, particularly the PIEZO2, STOML3 channel, were explained and discussed. They will have an impact on our understanding of neuropathic pain. Also, the poster sessions contained several reports on treatment of neuropathic pain.

Daily poster sessions were filled with attendees. Many discussions and interactions took place. Many interesting and often rare observations were displayed and discussed. For scientific papers and merits, traditional prizes (as, for example, the PK Thomas prize) were awarded by the PNS.

In the final ceremony, Steven S. Scherer took over the presidency from Mary M. Reilly.

The congress was held in a nice venue–the Melia Hotel Sitges. Traditionally, as is familiar to all PNS meetings, the atmosphere was good and open, and interactions were encouraged. It was excellently organized, and provided a useful platform to exchange ideas and to engage in networking.

25 Years of Russian-German Neurological Cooperation

By Profs. Peter Wolf and Alla B. Guekht

Inauguration photo from the association’s founding in 1992. Front row from the left: Profs. Peter Wolf, F. Manz, K. Schimrigk, Levon Badalyan, E. Gusev, and B. Guekht.

meeting on Diseases of the Nervous System — Mechanisms and Treatment was held April 6-7 in Moscow to celebrate the 25th anniversary of the Association for Promotion of German-Russian Cooperation in Neurology.

This association, whose name was later changed to the Russian-German Neurological Society, is perhaps not well known in global neurology, but played an important role in the first period after the European system shifts of 1989-1990. Until then, for about half a century, there had been extremely few possibilities for neuroscientists of West Germany and the Soviet Union to meet and exchange their views or to publish in each other’s journals.

The scientific developments on both sides of the Iron Curtain often  went different ways, and the post-World War II generations in East and West took little notice of each other. This was quite a change from earlier traditions, and symptomatic of the general disruption within Europe.

The new possibilities were first explored by Prof. Jefim Salganik of Gütersloh, a German neurologist who was born in the Soviet Union and had studied medicine in Moscow. He contacted and then visited Prof. Levon Badalyan of Moscow, who had been an opponent for his doctoral thesis.

In consequence, a visit of a group of neurologists from northern Germany was organized in February 1991. They met with a group of leading Russian neurologists and their disciples for a seminar, which was held in Moscow and Yaroslavl, Russia. It became an unforgettable experience for all participants. Transportation, lodgings, translations, and meeting facilities, including something as unusual at the time as video demonstrations, needed a lot of improvisation.

All difficulties were overcome by the local organizers, and the hospitality was overwhelming. There was great mutual curiosity about the methods and traditions that had developed, and time set aside for discussion was never sufficient. Thus, the last papers were delivered and discussed on the bus, as all drove back together to Moscow through the white winter landscape. It was one of the occasions where enduring friendships arise among people who until then had been foreigners to each other.

Both sides expressed a strong interest in establishing a platform for future exchange and meetings. Also, in the German group, many were strongly aware of Nazi Germany’s barbarous actions, especially in Eastern Europe. The German group found it their duty to be the first to reach out to Russian colleagues and integrate them into the common European agenda.

When in 1992 the Russian group was received in Germany for a second scientific encounter, the association was founded and registered in Germany, where it also came to function as a commission of the German Neurological Society. Leading neurologists from both countries (Profs. Badalyan, Gusev, Guekht, Schimrigk, Wolf, Haass, Salganik, Manz, and many others) contributed to the establishment and further development of the society.

In the following years, annual meetings alternating between the two countries took place, and informal fellowships for the training of young neurologists were privately organized. More colleagues became interested and joined the society. Over the years, as international contacts and exchange possibilities multiplied, the general meetings lost their uniqueness
and became rarer. However, in some subspecialties, bilateral cooperation intensified and deepened, especially in stroke, epilepsy, and neuromuscular diseases, where several early association members became national and international key players.

The 25th anniversary meeting was a welcome occasion to update newer research and to remember an initiative reflecting very well the spirit and optimism of the early 1990s, which definitely made a change for European neurology. 

Prof. Peter Wolf is from Dianalund and Florianópolis, and Prof. Alla B. Guekht is from Moscow.

Update on the Kasralainy Stroke Unit at Cairo University

By Prof. Ahmed Abdelalim

A stroke physician and assistants performed a transcranial duplex.

Egypt has the 15th largest population in the world, with approximately one-quarter of its citizens clustered in its capital, Cairo. Stroke medicine in Egypt has been facing many difficulties with implementation due to the economic problems and an inadequate number of stroke neurologists.

Kasralainy Medical School is the largest medical center in the Middle East, with a capacity of over 5,000 beds providing medical services to more than
2 million people per year, half of which are served in the emergency department. The first stroke unit was established over 20 years ago, but could not satisfy the need due to the rapidly growing population and difficulties with the insurance system.

The plan for a new stroke center was then created with great ambitions of going beyond offering medical services to providing stroke training and research opportunities to Egyptian, African, and Middle Eastern neurologists and to help raise community awareness. Over the years, the neurology department has sent many of its young members to European stroke centers, through grants, to be trained on modern stroke medicine together with in-house training on advanced life support and neurocritical care skills. Today, these neurologists have become the core of the new stroke unit and trainers to their younger colleagues.

The stroke team, including stroke nurses and administrative personnel.

In 2010, the hospital administration granted the place and funds to establish the new stroke unit. Due to the political circumstances in 2011, the project was halted until 2015, when the Kasralainy administration, led by Prof. Fathy Khodair, dean of the medical school, showed a great interest and determination to fulfill the project. In August 2016, the stroke unit was ready for a new start.

The new stroke unit has a capacity of 36 beds, which includes 14 intensive care (with ventilation capability), 14 intermediate care, four isolation, two thrombolytic therapy, and two resuscitation beds, with the capacity of providing thrombolytic stroke therapy concurrently for four or more patients. This makes the unit the largest high-dependency stroke unit in the Middle East fully run by neurologists, offering thrombolytic therapy and thrombectomy to all Egyptians free of charges. The unit provides advanced acute stroke treatment services, including neurosurgery, neurointervention, advanced neuroimaging, and neuro-rehabilitation for 1,500-2,000 patients per year.

The Kasralainy Medical School stroke unit.

The opening of the new stroke unit received another boost thanks to the new policy on supporting and promoting stroke medicine, together with the efforts of the Stroke Chapter of the Egyptian Society of Neurology, Psychiatry, and Neurosurgery to coordinate between stroke units on a national level and promote the use of guidelines and hospital-based registries. The training and research opportunities are further supported and extended by the WFN accreditation of the neurology department at Cairo University as a training center for English-speaking African neurologists.

The ongoing “revolution” of stroke medicine in Egypt has made the floor ready for great success for the new stroke treatment policy, with a better acute stroke treatment service and reduction of the national and regional burden of stroke. The new Kasralainy stroke unit is ready to play its leading role. 

Prof. Ahmed Abdelalim is the director of the Stroke Unit, Faculty of Medicine at Cairo University.

Filling the Gap: Report of the International Tropical Neurology Conference

By Chandrashekhar Meshram and Gagandeep Singh

Gagandeep Singh

Chandrashekhar Meshram

Tropical neurology is a pertinent subspecialty of neurology. However, in the past, it did not receive the attention it deserved. In the World Federation of Neurology (WFN), tropical neurology was introduced as one of the major themes during the World Congress of Neurology in New Delhi in 1989. A research group was formed and some outstanding international meetings were held, but only for a short period of time. The enthusiasm eventually waned, and there were no further meetings. Likewise, the Journal of Tropical and Geographical Neurology, initiated by Dr. Charles Poser, also faded quickly.

An international tropical neurology conference, held March 24-26, 2017, in Mumbai, India, was an effort to fill the gap. It was organized by the Indian Academy of Neurology under the aegis of the WFN. Dr. R. S. Wadia served as the organizing president, while Dr. Chandrashekhar Meshram was the organizing secretary. The conference, dedicated to Prof. Noshir H. Wadia, was inaugurated by WFN President Dr. Raad Shakir.

The 2017 Conference

Speakers of the International Tropical Neurology Conference 2017 demonstrated the revived interest in the topic.

The last credible meeting on tropical neurology was held in the mid-1990s. The organizers were mindful of the over 20-year gap. Nevertheless, the congress was an outstanding success. Attended by nearly 1,000 delegates, with 46 speakers eminent from Austria, Brazil, Honduras, India, Malaysia, Peru, Sri Lanka, South Africa, Tanzania, U.K., U.S., and Vietnam, the congress has completely filled the long gap. The topics discussed included neurology of common infections, cerebral malaria, Ebola virus, konzo, sarcocystosis, nodding syndrome, rabies, Zika virus, and bacterial meningitis, among others. Debate, CPC, neuroradiology, and neuropathology sessions were also part of the scientific program. There were standalone symposia on central nervous system tuberculosis, the neurology of HIV, encephalitis, poisoning, and neurocysticercosis. Seventy-nine papers were presented. Dr. Shakir highlighted the role of the WFN in training and education in the developing world.

Not only did the congress prove to be an academic bestseller, it achieved what could be, as well as what could not be, accomplished in the 20-year gap: reigniting a flame of interest in tropical and geographical neurology and resurrection of the WFN Research Group on Tropical Neurology. The research group was revived with Dr. Meshram, president, and Dr. Amilton Barreira, secretary general, in leadership roles.

Mission Objectives

The Research Group on Tropical Neurology was formed with a mission to foster research collaboration into poorly understood aspects of neurological disorders prevalent in the tropics and to disseminate knowledge at international and regional levels in this neglected area of neurology. One of the ways of achieving the mission objectives would be to organize regular biennial meetings of the Tropical Neurology Research Group in different locations, with a local emphasis on tropical disorders. The Research Group also will strive for representation of tropical neurological disorders in the scientific program of the World Congress of Neurology. An eventual undertaking should rightfully be the revival of the Journal of Tropical and Geographical Neurology.

Acknowledgements are due to all those who contributed to the Congress, including the eminent faculty, but most of all to the WFN for its generous support and to Dr. Shakir for the constant encouragement.

The State of Neurology in Aleppo

By Dr. Mohammad Bassam Hayek

A workshop about epilepsy was presented during a training course funded by the World Health Organization.

Aleppo, Syria, was subjected to a comprehensive war that directly affected all of its humanitarian services. Before July 2012, the difficulties were limited, with most related to security and transport problems.

However, by the end of July, the city had been torn into two large sections. With daily bombardments and clashes, the city’s population plummeted from 4.5 million to 1.5 million. Coinciding with this, the city experienced a complete absence of electricity, a severe decline in health services, and an insufficient number of beds available for hospitalization of stroke patients in government hospitals.

The quality of service provided by the private sector decreased. No MRI device was in service, either in the governmental or private sectors. Seventy percent of the CT machines no longer worked.

A number of neurologists (about 12 out of 30 doctors) left because of the security chaos. There were no neurologists in the area controlled by the armed people. Patients had to travel for several days to see a neurologist.

This was accompanied by the interruption of the supply of most neurological drugs from local markets, especially antiepileptics (valproate, carbamazepine, and phenytoin) and all antiparkinson drugs.

A hospital with 40 beds, built in 1943 and rehabilitated in 2014, has a physiotherapy and rehabilitation department with an EEG machine.

In addition to the unavailability of the necessary anticoagulants for stroke, one of the most important challenges was the loss of records for the treatment of multiple sclerosis (MS). About 900 patients had been periodically reviewed for free medical service and treatment (interferon beta of all kinds). Patients were dispersed, some migrated, and others had new attacks without finding the right medication (methylprednisolone) or the correct diagnosis.

All physiotherapy services disappeared. Although there were a number of therapists, the work was futile.

Due to the many injuries associated with shrapnel and peripheral nerve trauma, neurophysiologists for electromyogram and nerve conduction velocity tests were needed. There also was the occurrence of a number of cases of flaccid paralysis, and it was difficult to find treatment.

Turning the Corner

In January 2013, life was unbearable, and the city seemed to be gloomy without electricity or water, along with the decline of all basic services.

By 2014, a road to the city opened, bringing supplies to the besieged population. Small, private generators within neighborhoods delivered a limited supply of electricity. An MS committee was reorganized, and up to 365 patients were treated for free with beta interferon, but the drugs were from generic companies.

Initially, one MRI was returned to service. In the private sector, three private devices are now operating. However, there are no devices in government hospitals that can be used for free. The average cost of providing an MRI is $60. (The average monthly salary is $100.)

With the passing of time, the service situation stabilized, and the security improved. The U.N.’s international organizations reached the city and helped improve the health system.

Since mid-2014, medicine has become available in an acceptable, but insufficient manner. Currently, most essential neurological drugs are available. The most important are antiepileptic drugs (carbamazepine, sodium valproate, lamotrigine, levetiracetam, and clonazepam), but the supply is unstable. There are still difficulties in securing antiparkinson drugs, especially levodopa.

Continuing medical education and training have declined. The health sector has not prioritized the provision of services.

However, there have been improvements since 2015. The road from Aleppo to Damascus has become safer. Scientific activity has slowly returned, but fear still prevails over some doctors.

Some of the government hospitals are open, including a free neurology clinic at Ibn Khaldoun Hospital. There is free EEG service at three locations, and rehabilitation at one of the public hospitals is open to neurologic patients.

Training of neurologists of all ages is still an important need. This can be accomplished in seminars, scientific conferences, and specialized training programs. Neurological drugs through the World Health Organization are still needed.

Dr. Mohammad Bassam Hayek is a neurologist in Aleppo, Syria. He is vice president of the Syrian Society of Neurosciences and general director of Ibn Khaldoun Hospital.